NewsRx

Search our medical news database

Product Licensing

Healthcare company licenses three assisted reproduction technologies

Published in Women's Health Weekly, February 17th, 2005

MediCult (OSE:MEC) has licensed three inventions from high-profile research institutions within assisted reproduction.

The intention is to bring new clinically well-documented products to market carrying a significant value to our customers

These three inlicensed technologies are:

Statins as a stimulant factor in in vitro maturation of human occytes (IVM). Recent discoveries by scientists at the renowned Laboratory of Reproductive Biology, Rigshospitalet University Hospital in Copenhagen, indicate that inhibitors of the cholesterol metabolism stimulate Meiosis and improve fertility in mice. Through the license agreement MediCult...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook